Wednesday, September 7th, 2011 - Chalmers Dale
The widespread use of anti-inflammatories such as aspirin and ibuprofen for the relief of one of the most common long-term diseases for Australia seniors could be doing more harm than good.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used as pain and inflammation reducers for people with arthritis, however concerns over their safety when taken with other medication has caused alarm amongst health professionals.

A recent Danish study of over 1 million people revealed an increased heart attack and stroke risk from use of most NSAIDs.

Participants who used NSAIDs had a 91 per cent increased risk of cardiovascular death, similar to that for patients using rofecoxib, a widely used arthritic pain relief that was withdrawn in September 2004 over safety concerns.

There was also a 29 per cent increased risk of fatal or non-fatal stroke following use of a common over the counter anti-inflammatory drug.

The US Food and Drug Administration have already moved to put a warning on all NSAID labels, something that has not yet happened in Australia, regardless of the mounting evidence against their use.

The ongoing debate over NSAIDs has so far failed to provide an alternative for those wishing to seek an alternative anti-inflammatory relief for ailments such as arthritis until now.

A revolutionary naturally sourced anti-inflammatory relief product, based on ancient Indian and oriental medicine, has been relaunched in Australia to safely help millions of arthritis sufferers.

Cararthron, originally launched in Australia in 2002 with outstanding success, was based on three hand collected natural herbs, however due to the unavailability of the ingredients was discontinued.

It’s taken five years to reformulate, undergo all the efficacy, clinical and safety checks, and now the new Cararthron that is based on two commercially grown herbs is available again for arthritis sufferers.

Cararthron’s Australian distributor Dr Andrew Chew says arthritis is one of the most common long-term diseases in Australia with more than 3.1 million Australian’s estimated to be affected by the disease.

“There are more than 100 types of arthritis with osteoarthritis and rheumatoid arthritis the two most common types, but regardless of the type finding the right anti-inflammatory and pain relief is paramount,” Dr Chew says.

“Unfortunately for most people taking nonsteroidal anti-inflammatory drugs can be a major risk to their health and even increase the chance of heart attack or stroke.

“The original Cararthron was very well received when first launched in Australia because it has minimal side effects, and the new formula is effective and has been extensively tested.”

Cararthron’s new formula contains a blend of Scutellaria baicalensis, one of the 50 fundamental herbs used in traditional Chinese medicine, and Acacia catechu, a tree found in India and Asia, both used traditionally in oriental and ayurvedic medicine for their anti-inflammatory properties.

Dr Chew says Cararthron may provide an effective anti?inflammatory and analgesic effect to benefit joints affected by arthritis.

“Cararthron may also help protect against the signs of cartilage degeneration, assist in maintaining healthy cardiovascular function and reduces adverse effects ensuring most people, including the elderly, may use it,” Dr Chew says.

“NSAID’s side effects may include heart failure or kidney failure, increased blood pressure and clotting and potentially fatal bleeding from developing ulcers in the gut.

“If given the choice between a naturally sourced anti-inflammatory relief product and a NSAID product, I’m sure consumers will make up their own mind what is best for them.”

Arthritis is the eighth most frequently managed problem by GPs in Australia with more than $4 billion spent on the disease annually.